Skip to main content

Pharming Group announces that an agreement has been reached with the Spanish Ministry of Health to grant reimbursement for RUCONEST® (conestat alfa) in Spain.

We are delighted with this positive reimbursement decision by the Spanish Ministry of Health, as it means patients in Spain in need of new treatment options for hereditary angioedema will now be able to access RUCONEST®

- Sijmen de Vries - CEO
Cookies: This website uses cookies Check the cookies page for more information Accept Decline